ClinicalTrials.Veeva

Menu

Antabuse in Severe Alcoholism: an Open Controlled Study

P

Psykiatrisk Center Gentofte

Status and phase

Unknown
Phase 4

Conditions

Alcoholism

Treatments

Drug: antabuse (disulfiram)

Study type

Interventional

Funder types

Other

Identifiers

NCT00431262
EudraCT no. 2006-004921-27

Details and patient eligibility

About

Newly detoxified alcoholics (N=60) are randomised to either antabuse (disulfiram) treatment or the control group for a total of 6 months.All patients will receive cognitive behavioural treatment in groups. The hypothesis to be tested is that more of the patients who receive antabuse (disulfiram) will be alcohol free during the 6 months treatment period compared to the control group. The trial is open.

Sex

All

Ages

18 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Alcoholism
  • Living in the departments catchment area

Exclusion criteria

  • Pregnancy
  • Schizophrenia
  • Bipolar disorder
  • Other substance abuse
  • Dementia
  • Anorexia

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems